Handelsbanken Fonder AB Cuts Holdings in Agilent Technologies, Inc. $A

Handelsbanken Fonder AB cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 4.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 143,413 shares of the medical research company’s stock after selling 6,529 shares during the quarter. Handelsbanken Fonder AB owned approximately 0.05% of Agilent Technologies worth $19,514,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of A. Board of the Pension Protection Fund purchased a new position in Agilent Technologies in the fourth quarter valued at about $27,000. Navalign LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at approximately $27,000. Entrust Financial LLC purchased a new stake in Agilent Technologies during the 4th quarter worth about $31,000. Physician Wealth Advisors Inc. lifted its stake in Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after purchasing an additional 196 shares in the last quarter. Finally, Torren Management LLC purchased a new stake in Agilent Technologies in the 4th quarter worth approximately $32,000.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on A. Morgan Stanley lowered their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Barclays reduced their price target on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Wells Fargo & Company dropped their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Finally, UBS Group dropped their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $163.71.

Agilent Technologies Stock Up 2.8%

A opened at $113.64 on Thursday. The firm’s fifty day moving average is $114.79 and its 200 day moving average is $129.89. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. Agilent Technologies, Inc. has a fifty-two week low of $107.07 and a fifty-two week high of $160.27. The stock has a market cap of $32.11 billion, a price-to-earnings ratio of 25.09, a price-to-earnings-growth ratio of 2.33 and a beta of 1.22.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The business had revenue of $1.80 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.